Compare iShares JPMorgan USD Emerging Markets Bond ETF (EMB) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares JPMorgan USD Emerging Markets Bond ETF vs DENTSPLY SIRONA Inc — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $91.04 (market cap $12.87B), while DENTSPLY SIRONA Inc trades at $8.82 (market cap $1.73B). The key difference: iShares JPMorgan USD Emerging Markets Bond ETF is far larger — about 7.4× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while iShares JPMorgan USD Emerging Markets Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares JPMorgan USD Emerging Markets Bond ETF for 50 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| EMB | XRAY | |
|---|---|---|
Market Cap | $12.87B | $1.73B |
Volume | 14,946,002 | 6,198,582 |
Sector | Fixed Income | Health |
52-Week High | $97.74 | $14.68 |
52-Week Low | $90.14 | $8.52 |
Typical Hold Time | 50 Days | 72 Days |
Enterprise Value | — | $3.80B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EMB trades at $90.96 with minimal daily movement (+0.2%), showing technical bearish signals from moving averages while oscillators remain neutral. The stock faces resistance at $91-92 with support at $90. Recent dividend declarations of $0.41-0.44 per share provide income appeal, though key financial ratios remain undisclosed in current data.
The outlook appears cautious with technical indicators signaling bearish momentum. Income-focused investors may find value in the dividend yield, but limited fundamental data availability and bearish technical signals suggest careful evaluation is warranted. Market risks include broader economic pressures affecting bond yields and emerging market exposure.
DENTSPLY SIRONA (XRAY) trades at $8.54, near its 52-week low, with bearish technical indicators and mixed fundamentals. The company reported Q2 2026 EPS of $0.52 beating expectations but revenue declined 4.1% year-over-year. Net income remains negative at -$598 million for 2025, though margins show slight improvement. Analyst consensus is mixed with 37.5% buy ratings but a $13.40 price target suggesting 57% upside potential from current levels.
The stock presents a high-risk turnaround opportunity with significant upside if management's restructuring efforts succeed, but faces headwinds from declining sales, margin pressure, and competitive challenges in dental markets. Institutional ownership changes and ongoing transformation investments create both uncertainty and potential for recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares JPMorgan USD Emerging Markets Bond ETF
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
